riley mccormack
CIK 1536534 · Chief Executive Officer · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$43.03M
Companies
2
Total Filings
12
Lifetime Open-Market Net
$1.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMRC | Chief Executive Officer | 3,804,899 | $11.31 | $43.03M | $732.5K | 9 | 2026-05-21 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 2,325,000 | $28.80 | $66.96M | $929.0K | 3 | 2015-01-16 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-07 | Oruka Therapeutics, Inc. (ABIO) Delisted | Sell (S) | −550,000 | -$503.5K | EDGAR |
| 2014-02-04 | Oruka Therapeutics, Inc. (ABIO) Delisted | Buy (P) | +1,000,000 | $1.70M | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.